Rhenman & Partners Asset Management AB
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1599882
Stockholm, V7
Position in BMRN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,693,430
-$1,084,020 QoQ
Shares Held
207,000
-3.7% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. BMRN ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,100 | $37,163,984 | |
| 2 | INSM |
INSMED Inc
|
159,760 | $26,123,955 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,485 | $19,417,791 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
75,890 | $14,347,004 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
24,050 | $12,589,453 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
207,000 | $11,693,430 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,465 | $11,403,434 | |
| 8 | RPRX |
Royalty Pharma plc
|
233,000 | $11,177,010 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,693,430 | 207,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,777,450 | 215,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,108,964 | 186,650 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,226,260 | 149,650 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $18,732,850 | 265,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,473,449 | 250,623 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $25,620,705 | 364,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,705,995 | 251,500 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $20,743,250 | 237,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $27,238,650 | 282,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,622,400 | 380,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $32,938,400 | 380,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,879,000 | 225,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,286,460 | 254,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,090,490 | 237,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,601,800 | 140,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,962,000 | 220,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,412,750 | 265,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $18,549,600 | 240,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,350,400 | 160,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,591,800 | 180,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $44,721,900 | 510,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $56,630,452 | 744,354 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $23,434,600 | 190,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $15,619,402 | 184,845 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||